217 related articles for article (PubMed ID: 16288042)
1. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
Hibino S; Shibuya M; Hoffman MP; Engbring JA; Hossain R; Mochizuki M; Kudoh S; Nomizu M; Kleinman HK
Cancer Res; 2005 Nov; 65(22):10494-501. PubMed ID: 16288042
[TBL] [Abstract][Full Text] [Related]
2. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK
Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450
[TBL] [Abstract][Full Text] [Related]
3. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
5. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1.
Kazmin DA; Hoyt TR; Taubner L; Teintze M; Starkey JR
J Mol Biol; 2000 May; 298(3):431-45. PubMed ID: 10772861
[TBL] [Abstract][Full Text] [Related]
6. An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan.
Tashiro K; Monji A; Yoshida I; Hayashi Y; Matsuda K; Tashiro N; Mitsuyama Y
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):119-26. PubMed ID: 10229666
[TBL] [Abstract][Full Text] [Related]
7. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
8. The role of syndecan-4 and attached glycosaminoglycan chains on myogenic satellite cell growth.
Zhang X; Nestor KE; McFarland DC; Velleman SG
Matrix Biol; 2008 Sep; 27(7):619-30. PubMed ID: 18602469
[TBL] [Abstract][Full Text] [Related]
9. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis.
Tapon-Bretaudière J; Chabut D; Zierer M; Matou S; Helley D; Bros A; Mourão PA; Fischer AM
Mol Cancer Res; 2002 Dec; 1(2):96-102. PubMed ID: 12496356
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional peptides derived from homologous loop regions in the laminin alpha chain LG4 modules interact with both alpha 2 beta 1 integrin and syndecan-2.
Yokoyama F; Suzuki N; Kadoya Y; Utani A; Nakatsuka H; Nishi N; Haruki M; Kleinman HK; Nomizu M
Biochemistry; 2005 Jul; 44(28):9581-9. PubMed ID: 16008343
[TBL] [Abstract][Full Text] [Related]
11. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
12. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
Kuniyasu H; Oue N; Tsutsumi M; Tahara E; Yasui W
Clin Cancer Res; 2001 Dec; 7(12):4067-72. PubMed ID: 11751503
[TBL] [Abstract][Full Text] [Related]
14. Cyclic peptides from the loop region of the laminin alpha 4 chain LG4 module show enhanced biological activity over linear peptides.
Yokoyama F; Suzuki N; Haruki M; Nishi N; Oishi S; Fujii N; Utani A; Kleinman HK; Nomizu M
Biochemistry; 2004 Oct; 43(42):13590-7. PubMed ID: 15491165
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
[TBL] [Abstract][Full Text] [Related]
16. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding fragment of fibronectin in human articular cartilage in culture.
Yasuda T; Poole AR; Shimizu M; Nakagawa T; Julovi SM; Tamamura H; Fujii N; Nakamura T
Arthritis Rheum; 2003 May; 48(5):1271-80. PubMed ID: 12746900
[TBL] [Abstract][Full Text] [Related]
19. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
20. Murine epidermal growth factor (EGF) fragment (33-42) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis.
Nelson J; Allen WE; Scott WN; Bailie JR; Walker B; McFerran NV; Wilson DJ
Cancer Res; 1995 Sep; 55(17):3772-6. PubMed ID: 7543818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]